Drug intelligence / Profile preview

fuke shiwei tablets

Development stage: Unknown
Lead developer: Chongqing Sainuo Biological Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Fuke Shiwei Tablets (妇科十味片) is a Traditional Chinese Medicine (TCM) oral formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is composed of ten herbal ingredients, including Cyperi Rhizoma, Angelicae Sinensis Radix, and Paeoniae Radix Alba, which are traditionally used to soothe the liver, regulate Qi, and nourish the blood. The drug is specifically indicated for the treatment of irregular menstruation, dysmenorrhea, and various premenstrual and postmenstrual symptoms. It works by addressing the underlying TCM patterns of liver Qi stagnation and blood deficiency, which are associated with menstrual pain and cycle irregularities.

Brand names: 妇科十味片Fuke Shiwei Tablets
Other names: Fuke Shiwei Pian

Beyond the preview

Go deeper on fuke shiwei tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuke shiwei tablets.

Explore the full profile